All articles tagged with #uterine cancer
Originally Published 4 months ago — by SciTechDaily
A study reveals that tamoxifen, a life-saving breast cancer drug, can directly activate the PI3K pathway in the uterus, increasing the risk of secondary tumors without the need for genetic mutations, challenging previous assumptions about therapy-related cancers and opening avenues for safer treatments.
Originally Published 5 months ago — by BuzzFeed
Uterine cancer, the most common gynecological cancer in the U.S., is rising, especially among women over 50, with Black women experiencing higher mortality rates. Risk factors include age, obesity, genetic syndromes like Lynch syndrome, hormone therapy, and certain hair products. Symptoms such as post-menopausal bleeding and pelvic pain should prompt medical evaluation, though no screening test exists. Awareness of risk factors and early signs can aid in timely diagnosis and treatment.
Originally Published 5 months ago — by BuzzFeed
Uterine cancer, the most common gynecological cancer in the U.S., is rising, especially among women over 50, with Black women experiencing higher mortality rates. Risk factors include age, obesity, genetic syndromes like Lynch syndrome, hormone therapy, and certain hair products. Symptoms such as post-menopausal bleeding and pelvic pain should prompt medical evaluation, as there is no screening test for early detection. Awareness of risk factors and symptoms can help women seek timely care and potentially improve outcomes.
Originally Published 5 months ago — by Yahoo Home
Uterine cancer, the most common gynecological cancer, is increasing in prevalence, especially among women over 50, with Black women facing higher mortality rates. Risk factors include age, obesity, genetic syndromes like Lynch syndrome, hormone therapy, and certain lifestyle factors. Symptoms such as post-menopausal bleeding and pelvic pain should prompt medical evaluation, although there is no current screening test. Awareness of risk factors and early signs is crucial for early detection and treatment.
Originally Published 5 months ago — by BuzzFeed
Uterine cancer, the most common gynecological cancer in the U.S., is rising, especially among women over 50, with Black women experiencing higher mortality rates. Risk factors include age, obesity, genetic syndromes like Lynch syndrome, hormone therapy, and certain hair products. Symptoms such as post-menopausal bleeding and pelvic pain should prompt medical evaluation, though no screening test exists. Awareness of risk factors and early signs can help in timely diagnosis and treatment.
Originally Published 5 months ago — by HuffPost
Uterine cancer, particularly endometrial cancer, is increasing among women, especially post-menopausal women and Black women who face higher mortality rates. Risk factors include obesity, genetic syndromes like Lynch syndrome, hormone therapy, and PCOS. Symptoms such as abnormal bleeding should prompt medical consultation, as there is no current screening test. The rise in cases is linked to hormonal influences and obesity, with Black women experiencing a disproportionate increase in incidence and mortality. Awareness of risk factors and symptoms is crucial for early detection and treatment.
Originally Published 1 year ago — by Bored Panda
Sara Director, a 9/11 survivor and lawyer, has successfully advocated for the recognition of uterine cancer as the 69th 9/11-related cancer, ensuring free health screenings and treatments for affected women. Her efforts have provided support for female victims and their families, allowing them to file claims for compensation. Sara's personal experience with 9/11 has shaped her legal career, and she continues to raise awareness about the importance of self-care and women's health, especially for those exposed to toxins during the aftermath of the terrorist attack.
Originally Published 2 years ago — by OregonLive
A 71-year-old male with an enlarged prostate seeks a surgical solution for frequent nighttime urination, but is concerned about side effects. The most common surgical treatment is transurethral resection of the prostate (TURP), but there are now less-invasive options available. Adding progesterone to hormone replacement therapy reduces the risk of uterine cancer by inhibiting cell growth and promoting cell differentiation. Solar purpura, a condition characterized by easy bruising and tearing of the skin, is caused by cumulative sun damage and can be treated with citrus bioflavonoid supplements or a diet high in citrus and fresh fruits and vegetables.
Originally Published 2 years ago — by Reuters
Thousands of Black women have filed lawsuits against cosmetic companies, including L'Oreal and Revlon, alleging that hair relaxers containing chemicals have increased their risk of developing uterine cancer and that the companies failed to provide adequate warnings. The lawsuits come after a study by the U.S. National Institutes of Health found an association between frequent use of chemical hair relaxers and uterine cancer. The companies deny the claims and argue that the study did not establish a definitive link. The success of the legal claims will depend on proving that the products were harmful and that the companies knew or should have known about the risks. The cases have been consolidated in a Chicago federal court.
Originally Published 2 years ago — by OregonLive
Estetrol hormone therapy, a new drug soon to be approved by the FDA, is being considered as a treatment for urine infections and overall well-being in a breast cancer survivor. Estetrol is a human estrogen that stimulates the lining of the vulva and vagina, which can help prevent urine infections. While there is minimal theoretical risk of breast cancer with estetrol, there is a potential risk of uterine cancer. However, combining estrogens with progesterone significantly reduces the risk of uterine cancer. The use of topical estrogens may be a safer option to reduce the risk of urine infections, but it is important to discuss the risks with an oncologist.
Originally Published 2 years ago — by NBC News
Thousands of Black women have filed lawsuits against companies like L'Oréal and Revlon, alleging that chemical hair straighteners have caused them uterine cancer and infertility. Studies have shown that the chemicals in these products, such as parabens and phthalates, can disrupt the hormone-regulating endocrine system and increase the risk of uterine cancer. While the studies do not definitively prove causation, they have raised concerns about the safety of these products. Many of the women involved in the lawsuits have undergone hysterectomies, resulting in the loss of their ability to have children. The women are calling for stricter regulation and labeling of these products, as well as holding the manufacturers accountable for the harm caused.
Originally Published 2 years ago — by NBC News
Chemical hair relaxers used by Black women have been linked to increased rates of uterine cancer, fibroid tumors, infertility, and breast cancer, according to several landmark studies. The latest research from Boston University's Black Women's Health Study found that postmenopausal Black women who used chemical hair relaxers for more than five years or more than twice a year had an increased risk of developing uterine cancer. These relaxers contain endocrine-disrupting chemicals, such as phthalates and parabens, which can affect hormone levels and have harmful effects on the body. The FDA has proposed a ban on hair-smoothing and hair-straightening products containing formaldehyde. Stricter regulations and safer alternatives, such as heat straightening, may help reduce exposure to these harmful chemicals. Black women are advised to monitor their health, consult with doctors, and be aware of potential risks associated with chemical hair straighteners.
Originally Published 2 years ago — by Yahoo Life
Long-term use of chemical hair relaxers by postmenopausal Black women is associated with an increased risk of uterine cancer, according to a study from Boston University's Black Women's Health Study. The study found that women who used hair relaxers more than twice a year or for more than five years had a greater than 50% increased risk of uterine cancer. The specific ingredients in hair relaxers that may be associated with health risks are difficult to determine due to proprietary formulations. These products are known to contain potentially harmful toxicants and carcinogens. The FDA plans to propose a ban on formaldehyde and other chemicals in hair smoothing and straightening products. It is important to choose hair care products wisely and consider longer intervals between chemical hair relaxing treatments.
Originally Published 2 years ago — by WLKY Louisville
Virginia Moore, the sign language interpreter who accompanied Gov. Beshear during several COVID-19 updates, has died. Beshear announced her death on Facebook and described her as a "rock of stability and grace during the pandemic." Moore had announced in October 2020 that she had stage 1 uterine cancer and left the daily pandemic briefings, but after treatment, she said she was cancer-free a few weeks later.
Originally Published 2 years ago — by Yahoo Entertainment
Karen Smith, who got uterine cancer from toxic chemicals near Ground Zero, is one of the first women to be certified by the World Trade Center Health Program, which added uterine cancer to the list of illnesses caused by 9/11 in January 2023. Smith is now eligible to seek compensation for her illness through the Victim Compensation Fund. Once certified, individuals are entitled to free healthcare for the illness and can make claims for compensation, lost wages, and past medical expenses. Smith hopes her story brings awareness to other women who may be suffering from a 9/11 related illness.